ALLARITY THERAPEUTICS, INC. Inactive Instrument
Calendar Allarity Therapeutics, Inc. Nasdaq Stockholm
Equities
ALLR
US0167441049
Chart calendar Allarity Therapeutics, Inc.
56840ee171c75365f36d8a867b679d47.3_o0WaPT6oVFujZvuZOKZUfZj-R8U5ycCt-210YopDs.iJFkNpGKgeMoj3As6OXpDHWU0JI2N93qc4rltSNvzlizoGAP8Lme_ACDVQ~7f72b68d10c0aec6a50691ba12daa825
Upcoming events on Allarity Therapeutics, Inc.
Past events on Allarity Therapeutics, Inc.
| 31/03/2024 | Extraordinary Shareholders Meeting |
| 08/03/2024 12:15 | Q4 2023 Earnings Release |
| 28/02/2024 | Biomarkers Congress |
| 13/11/2023 | Biomarkers Europe Congress |
| 18/10/2023 | ThinkEquity Conference |
| 23/06/2023 18:00 | Extraordinary Shareholders Meeting |
| 03/06/2023 14:00 | American Society of Clinical Oncology Conference - Abstract # 3130 |
| 19/03/2023 | Extraordinary Shareholders Meeting |
| 03/02/2023 18:00 | Annual General Meeting |
| 02/12/2022 18:00 | Annual General Meeting |
| 15/11/2022 21:01 | Q3 2022 Earnings Release |
| 11/10/2022 21:05 | Interim 2022 Earnings Release |
| 29/09/2022 20:00 | Ladenburg Thalmann Healthcare Conference |
| 27/05/2022 22:37 | Q1 2022 Earnings Release |
| 17/05/2022 00:40 | FY 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,12 0,54 -78.12% | 0,00 0,15 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -9,81 -17,2 42.98% | -9,31 -8,96 -3.88% | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -21,8 -17,0 -28.61% | -9,47 -9,13 -3.68% | 0,00 | -32,7 -31,5 -3.64% | -17,1 -16,7 -2.5% | -23,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,8 -17,3 -49.27% | -9,33 -7,71 -21.03% | 0,00 | -17,6 -20,0 12.17% | -11,8 -14,5 18.58% | -16,5 |
|
Net income Million USD | Released Forecast Spread | -20,4 -15,4 -32.08% | -7,53 -6,85 -9.81% | -26,6 | -21,1 -20,4 -3.35% | -20,4 -14,5 -40.66% | -16,5 |
|
EPS USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | -61 880 -60 760 -1.84% | -205 -4 117 95.02% | -28,6 |
| Announcement Date | 31/03/20 | 31/03/21 | 17/05/22 | 13/03/23 | 08/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -4,30 -5,35 19.51% | -4,33 -5,61 22.86% | -4,56 -3,30 -38.43% | -4,97 -4,33 -14.67% | -3,66 -3,63 -0.94% | -4,16 -3,59 -15.9% | -4,43 -3,51 -25.95% | -4,88 -4,47 -9.15% | -4,94 | -5,92 | -6,22 | -6,53 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,31 -5,35 19.42% | -4,65 -5,61 17.09% | -5,03 -2,89 -74.18% | -3,14 -4,38 28.24% | -3,35 -3,63 7.53% | -2,38 -3,59 33.63% | -4,45 -3,51 -26.55% | -1,64 -4,34 62.19% | -3,16 | -3,10 | -5,21 | -5,02 |
|
Net income Million USD | Released Forecast Spread | -4,65 -5,35 12.97% | -4,66 -5,61 17.02% | -6,68 -2,89 -131.33% | -3,10 -4,38 29.13% | -3,36 -3,63 7.42% | -9,79 -3,59 -172.89% | -5,55 -3,51 -58% | -1,72 -4,34 60.28% | -3,16 | -3,10 | -5,21 | -5,02 |
|
EPS USD | Released Forecast Spread | -15 680 -18 480 15.15% | -14 560 -19 320 24.64% | -19 040 -7 140 -166.67% | -6 440 -11 760 45.24% | -3 544 -6 304 43.78% | -526 -224 -134.85% | -44,8 -163 72.58% | -5,00 | -10,6 | -5,60 | -6,40 | -6,20 |
| Announcement Date | 27/05/22 | 22/08/22 | 14/11/22 | 13/03/23 | 11/05/23 | 14/08/23 | 14/11/23 | 08/03/24 | - | - | - | - |
More events
